KemPharm Inc. (NASDAQ: KMPH) on January 24, 2023, started off the session at the price of $6.27, plunging -10.53% from the previous trading day. During the day, the shares moved up to $6.30 and dropped to $5.58 before settling in for the closing price of $6.27. Within the past 52 weeks, KMPH’s price has moved between $4.00 and $7.38.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
The company achieved an average annual earnings per share of 34.10%. With a float of $30.28 million, this company’s outstanding shares have now reached $34.49 million.
Let’s look at the performance matrix of the company that is accounted for 24 employees. In terms of profitability, gross margin is +91.92, operating margin of +26.98, and the pretax margin is -29.74.
KemPharm Inc. (KMPH) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of KemPharm Inc. is 10.29%, while institutional ownership is 22.80%. The most recent insider transaction that took place on Jan 13, was worth 3,690. In this transaction CFO, Secretary & Treasurer of this company bought 635 shares at a rate of $5.81, taking the stock ownership to the 9,277 shares. Before that another transaction happened on Jan 13, when Company’s Chief Executive Officer bought 9,500 for $5.44, making the entire transaction worth $51,679. This insider now owns 19,973 shares in total.
KemPharm Inc. (KMPH) Latest Financial update
As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$0.7 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.12) by -$0.58. This company achieved a net margin of -29.86 while generating a return on equity of -28.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.10% per share during the next fiscal year.
KemPharm Inc. (NASDAQ: KMPH) Trading Performance Indicators
KemPharm Inc. (KMPH) is currently performing well based on its current performance indicators. A quick ratio of 10.10 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of KemPharm Inc. (KMPH)
KemPharm Inc. (NASDAQ: KMPH) saw its 5-day average volume 0.35 million, a positive change from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 83.88%. Additionally, its Average True Range was 0.33.
During the past 100 days, KemPharm Inc.’s (KMPH) raw stochastic average was set at 53.87%, which indicates a significant decrease from 62.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.23% in the past 14 days, which was higher than the 61.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.79, while its 200-day Moving Average is $5.12. Nevertheless, the first resistance level for the watch stands at $6.08 in the near term. At $6.55, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.80. If the price goes on to break the first support level at $5.36, it is likely to go to the next support level at $5.11. The third support level lies at $4.64 if the price breaches the second support level.
KemPharm Inc. (NASDAQ: KMPH) Key Stats
Market capitalization of the company is 188.05 million based on 34,505K outstanding shares. Right now, sales total 28,650 K and income totals -8,560 K. The company made 2,870 K in profit during its latest quarter, and -6,620 K in sales during its previous quarter.